With 2.57 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.38 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $23.78 whereas the lowest price it dropped to was $23.24. The 52-week range on BTSG shows that it touched its highest point at $25.57 and its lowest point at $10.15 during that stretch. It currently has a 1-year price target of $28.10. Beta for the stock currently stands at 2.38.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BTSG was up-trending over the past week, with a rise of 3.60%, but this was up by 0.81% over a month. Three-month performance surged to 30.84% while six-month performance rose 35.26%. The stock gained 38.52% in the past year, while it has gained 118.63% so far this year. A look at the trailing 12-month EPS for BTSG yields 0.28 with Next year EPS estimates of 1.06. For the next quarter, that number is 0.18. This implies an EPS growth rate of 53.28% for this year and 23.33% for next year. EPS is expected to grow by 31.33% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 60.10%.
Float and Shares Shorts:
At present, 175.18 million BTSG shares are outstanding with a float of 93.35 million shares on hand for trading. On 2025-06-13, short shares totaled 15.33 million, which was 872.0000000000001 higher than short shares on 1747267200. In addition to Mr. Jon B. Rousseau as the firm’s Chairman, President & CEO, Ms. Lisa Nalley serves as its Chief of Staff & Senior VP of Human Resources.
Institutional Ownership:
Through their ownership of 0.96206003 of BTSG’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, BTSG reported revenue of $2878129000.0 and operating income of $50739000.0. The EBITDA in the recently reported quarter was $92900000.0 and diluted EPS was $0.14.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BTSG since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BTSG analysts setting a high price target of 37.0 and a low target of 25.0, the average target price over the next 12 months is 28.10417. Based on these targets, BTSG could surge 56.85% to reach the target high and rise by 5.98% to reach the target low. Reaching the average price target will result in a growth of 19.14% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.78611 being high and $0.43673 being low. For BTSG, this leads to a yearly average estimate of $0.5726.
